5 research outputs found

    Agglomeration of the poly(butadiene‐styrene) latex triggered by CO 2

    No full text

    An electrolyte-rich nano-organic cathode constructs an ultra-high voltage Zinc-ion battery

    No full text
    To realize green and sustainable energy storage systems, it is urgent to propose emerging strategies to construct and understand the relationship between electrode materials and electrolytes. Based on the strategy of storing the electrolyte in an organic cathode, we prepare a Zn2+-doped polyaniline (PAZ) nano-organic cathode with a re-doping method, which possesses high crystallinity in the (0 1 0) plane and high conductivity compared with conventional H+-doped polyaniline (PA). The resultant Zn//PAZ battery exhibits outstanding electrochemical performance for 3000 cycles at an ultra-high voltage of 2.4 V, attributed to the enhancement of electrolyte concentration and reduction of free water stemming from the dedoping of PAZ. A hybrid charge storage mechanism including Zn2+ and multi-anions insertion/extraction is also demonstrated for the Zn//PAZ batteries during the charge/discharge process. To further expand the practical applications of the strategy, we manufacture an electrolyte-free Zn//PAZ battery, which achieves acceptable performance for 400 cycles. This research provides insight into the relationship between the electrolyte and re-doped polyaniline organic cathode and opens a new avenue for emerging Zinc batteries

    A Wearable Self-Charging Electroceutical Device for Bacteria-Infected Wound Healing

    No full text
    The prolonged wound-healing process caused by pathogen infection remains a major public health challenge. The developed electrical antibiotic administration typically requires metal electrodes wired to a continuous power supply, restricting their use beyond clinical environments. To obviate the necessity for antibiotics and an external power source, we have developed a wearable synergistic electroceutical device composed of an air self-charging Zn battery. This battery integrates sustained tissue regeneration and antibacterial modalities while maintaining more than half of the initial capacity after ten cycles of chemical charging. In vitro bacterial/cell coculture with the self-charging battery demonstrates inhibited bacterial activity and enhanced cell function by simulating the endogenous electric field and dynamically engineering the microenvironment with released chemicals. This electroceutical device provides accelerated healing of a bacteria-infected wound by stimulating angiogenesis and modulating inflammation, while effectively inhibiting bacterial growth at the wound site. Considering the simple structure and easy operation for long-term treatment, this self-charging electroceutical device offers great potential for personalized wound care

    Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice

    Get PDF
    Abstract Endothelial dysfunction represents a major cardiovascular risk factor for hypertension. Sp1 and Sp3 belong to the specificity protein and Krüppel-like transcription factor families. They are ubiquitously expressed and closely associated with cardiovascular development. We investigate the role of Sp1 and Sp3 in endothelial cells in vivo and evaluate whether captopril, an angiotensin-converting enzyme inhibitor (ACEI), targets Sp1/Sp3 to exert its effects. Inducible endothelial-specific Sp1/Sp3 knockout mice are generated to elucidate their role in endothelial cells. Tamoxifen-induced deletion of endothelial Sp1 and Sp3 in male mice decreases the serum nitrite/nitrate level, impairs endothelium-dependent vasodilation, and causes hypertension and cardiac remodeling. The beneficial actions of captopril are abolished by endothelial-specific deletion of Sp1/Sp3, indicating that they may be targets for ACEIs. Captopril increases Sp1/Sp3 protein levels by recruiting histone deacetylase 1, which elevates deacetylation and suppressed degradation of Sp1/Sp3. Sp1/Sp3 represents innovative therapeutic target for captopril to prevent cardiovascular diseases
    corecore